Document:

EX-10.11

 Exhibit 10.11 

TANGO THERAPEUTICS, INC. 

SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN 
  

	1.	 Purpose 

This Senior Executive Cash Incentive Bonus Plan (the “Incentive Plan”) is intended to provide an incentive for superior work and to
motivate eligible executives of Tango Therapeutics, Inc. (the “Company”) and its subsidiaries toward even higher achievement and business results, to tie their goals and interests to those of the Company and its stockholders and to enable
the Company to attract and retain highly qualified executives. The Incentive Plan is for the benefit of Covered Executives (as defined below). 
  

	2.	 Covered Executives 

From time to time, the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) may select
certain key executives (the “Covered Executives”) to be eligible to receive bonuses hereunder. Participation in this Plan does not change the “at will” nature of a Covered Executive’s employment with the Company. 

 

	3.	 Administration 

The Compensation Committee shall have the sole discretion and authority to administer and interpret the Incentive Plan. 

 

	4.	 Bonus Determinations 

(a) Corporate Performance Goals. A Covered Executive may receive a bonus payment under the Incentive Plan based upon the attainment of
one or more performance objectives that are established by the Compensation Committee and relate to financial and operational metrics with respect to the Company or any of its subsidiaries (the “Corporate Performance Goals”), including:
cash flow (including, but not limited to, operating cash flow and free cash flow); research and development, publication, clinical and/or regulatory milestones; revenue; corporate revenue; earnings before interest, taxes, depreciation and
amortization; net income (loss) (either before or after interest, taxes, depreciation and/or amortization); changes in the market price of the Company’s common stock; economic value-added; acquisitions or strategic transactions, including
licenses, collaborations, joint ventures or promotion arrangements; operating income (loss); return on capital, assets, equity, or investment; stockholder returns; return on sales; gross or net profit levels; productivity; expense efficiency;
margins; operating efficiency; customer satisfaction; working capital; earnings (loss) per share of the Company’s common stock; sales or market shares; operating income and/or net annual recurring revenue; or any other performance goal selected
by the Compensation Committee, any of which may be (A) measured in absolute terms or compared to any incremental increase, (B) measured in terms of growth, (C) compared to another company or companies or to results of a peer group,
(D) measured against the market as a whole and/or as compared to applicable market indices and/or (E) measured on a pre-tax or post-tax basis (if applicable).
Further, any Corporate Performance Goals may be used to measure the performance of the Company as a whole or a business unit or other segment of the Company, or one or more product lines or specific markets. The Corporate Performance Goals may
differ from Covered Executive to Covered Executive. 

 (b) Calculation of Corporate Performance Goals. At the beginning of each applicable
performance period, the Compensation Committee will determine whether any significant element(s) will be included in or excluded from the calculation of any Corporate Performance Goal with respect to any Covered Executive. In all other respects,
Corporate Performance Goals will be calculated in accordance with the Company’s financial statements, generally accepted accounting principles, or under a methodology established by the Compensation Committee at the beginning of the performance
period and that is consistently applied with respect to a Corporate Performance Goal in the relevant performance period. 
 (c) Target;
Minimum; Maximum. Each Corporate Performance Goal shall have a “target” (100 percent attainment of the Corporate Performance Goal) and may also have a “minimum” hurdle and/or a “maximum” amount. 

(d) Bonus Requirements; Individual Goals. Except as otherwise set forth in this Section 4(d): (i) any bonuses paid to Covered
Executives under the Incentive Plan shall be based upon objectively determinable bonus formulas that tie such bonuses to one or more performance targets relating to the Corporate Performance Goals, (ii) bonus formulas for Covered Executives
shall be adopted in each performance period by the Compensation Committee and communicated to each Covered Executive at the beginning of each performance period and (iii) no bonuses shall be paid to Covered Executives unless and until the
Compensation Committee makes a determination with respect to the attainment of the performance targets relating to the Corporate Performance Goals. Notwithstanding the foregoing, the Compensation Committee may adjust bonuses payable under the
Incentive Plan based on achievement of one or more individual performance objectives or pay bonuses (including, without limitation, discretionary bonuses) to Covered Executives under the Incentive Plan based on individual performance goals and/or
upon such other terms and conditions as the Compensation Committee may in its discretion determine. 
 (e) Individual Target Bonuses.
The Compensation Committee shall establish a target bonus opportunity for each Covered Executive for each performance period. For each Covered Executive, the Compensation Committee shall have the authority to apportion the target award so that a
portion of the target award shall be tied to attainment of Corporate Performance Goals and a portion of the target award shall be tied to attainment of individual performance objectives. 

(f) Employment Requirement. Subject to any additional terms contained in a written agreement between the Covered Executive and the
Company, the payment of a bonus to a Covered Executive with respect to a performance period shall be conditioned upon the Covered Executive’s employment by the Company on the bonus payment date. If a Covered Executive was not employed for an
entire performance period, the Compensation Committee may pro rate the bonus based on the number of days employed during such period. 

  
 2 

	5.	 Timing of Payment 

(a) With respect to Corporate Performance Goals established and measured on a basis more frequently than annually (e.g., quarterly or
semi-annually), the Corporate Performance Goals will be measured at the end of each performance period after the Company’s financial reports with respect to such period(s) have been published. If the Corporate Performance Goals and/or
individual goals for such period are met, payments will be made as soon as practicable following the end of such period, but not later 74 days after the end of the fiscal year in which such performance period ends. 

(b) With respect to Corporate Performance Goals established and measured on an annual or multi-year basis, Corporate Performance Goals will be
measured as of the end of each such performance period (e.g., the end of each fiscal year) after the Company’s financial reports with respect to such period(s) have been published. If the Corporate Performance Goals and/or individual goals for
any such period are met, bonus payments will be made as soon as practicable, but not later than 74 days after the end of the relevant fiscal year. 

(c) For the avoidance of doubt, bonuses earned at any time in a fiscal year must be paid no later than 74 days after the last day of such
fiscal year. 
  

	6.	 Amendment and Termination 

The Company reserves the right to amend or terminate the Incentive Plan at any time in its sole discretion. 

 

	7.	 Company Recoupment Rights 

A Covered Executive’s rights with respect to any award granted pursuant to the Incentive Plan shall in all events be subject to reduction,
cancellation, forfeiture or recoupment to the extent necessary to comply with (i) any right that the Company may have under any Company clawback, forfeiture or recoupment policy as in effect from time to time or other agreement or arrangement
with a Covered Executive, or (ii) applicable law. 
 Adopted June 9, 2021, subject to the Closing (as defined in the Agreement and
Plan of Merger, dated as of April 13, 2021, by and among the Company (formerly known as BCTG Acquisition Corp.), BCTG Merger Sub Inc., and Tango Therapeutics, Inc.) 

  
 3Exhibit 10.1

 

Execution Version

 

AGREEMENT

 

THIS
AGREEMENT (this “Agreement”) is dated as of August 11, 2021 (the “Effective Date”) by and between
Hong Ye Hong Kong Shareholding Co., Limited, a Hong Kong company (“Hong Ye”), and Alberton Acquisition Corporation,
a British Virgin Islands Company (the “Company”). Hong Ye and Company are sometimes referred to collectively as the
“Parties”, and each, individually, as a “Party.”

 

WHEREAS,
Hong Ye is the sponsor of the Company and has provided working capital loans to the Company since its closing of its initial public offering
as set forth in Schedule A to the Company until the closing of its initial business combination (collectively, the “Working
Capital Loans”) evidenced by certain promissory notes issued by the Company (collectively, the “Hong Ye Notes”);

 

WHEREAS,
pursuant to the registration statement in Form S-1 (SEC file No. 333-227652) in connection with the initial public offering of the Company,
the Hong Ye Notes would either be paid upon the closing of an initial business combination, without interest, or at the discretion of
Hong Ye, up to $1,500,000 may be converted into units at a price of $10.00 per unit which would be identical to the private units issued
in the private placement in conjunction with the Company’s initial public offering;

 

WHEREAS,
the Company has entered into that certain Merger Agreement (as amended, the “Merger Agreement”) dated October 27, 2020
by and among the Company, Alberton Merger Subsidiary Inc., a Nevada corporation and a wholly-owned subsidiary of the Company (“Merger
Sub”), and SolarMax Technology, Inc., a Nevada corporation (“SolarMax”), pursuant to which SolarMax will
merge (the “Merger”) with and into Merger Sub and SolarMax will survive the Merger as a wholly-owned subsidiary of
the Company; and

 

WHEREAS,
the Merger Agreement provides that the Company will settle its obligations under the promissory notes that were outstanding on September
3, 2020 by delivery of ordinary shares of the Company owned by its sponsor and its affiliate;

 

WHEREAS,
the Company and Hong Ye have agreed that, 50% of the aggregate outstanding balance of principal amount of the Hong Ye Notes (the “Conversion
Payable”), shall be converted (the “Conversion”) and issued to Hong Ye in the form of ordinary shares (the
“Conversion Shares”) of the Company, no par value (“Ordinary Shares”) , subject only to (i) the
agreement of SolarMax to the terms of this Agreement and (ii) the closing of the Merger pursuant to the Merger Agreement, as the same
shall be amended from time to time, , including an amendment consistent with the Company’s obligations under this Agreement;

 

WHEREAS,
the approval of the Merger is to be submitted to the Company’s shareholders for their approval pursuant to a proxy statement/prospectus
on a Form S-4 (the “Proxy Statement”) at a special meeting (the “Special Meeting”) of the Company’s
shareholders;

 

WHEREAS,
the Board of Directors of the Company deemed that the Conversion is in the best interests of the Company; and

 

WHEREAS,
the Company has authorized sufficient Ordinary Shares for issuance with regards to the Conversion.

 

NOW
THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Hong Ye and the Company agree as follows

 

1.
Conversion. Upon the request of the Company, the Convertible Payable shall be converted into Ordinary Shares of the Company
immediately prior to, but subject to the completion of, upon the closing of the Merger pursuant to the Merger Agreement, at a conversion
price which shall be equal to ten (10) times the average trading price of the rights of the Company, the trading symbol for which is “ALACR,”
during a period of twenty-five (25) trading days ending on the second trading day prior to mailing of the final Proxy Statement to the
Company’s shareholders in connection with the Special Meeting. Immediately prior to the closing of the Merger, the Company shall
instruct its transfer agent to issue the Conversion Shares to Hong Ye or its designee.

 

     

     

    

 

2.
Registration. The Company shall file a registration statement on Form S-1 which covers the Conversion Shares. The Company
will file such registration statement as soon as possible after the Company has filed an amendment to its Proxy Statement which includes
SolarMax’s consolidated financial statements for the six months ended June 30, 2021. In the event that the registration statement
covering the Conversion Shares has not been declared effective by the Securities and Exchange Commission within fifteen (15) business
days after the closing of the Merger (other than as a result of the failure of Hong Ye to comply with Section 3 of this Agreement), the
Conversion Shares shall be automatically forfeited with no action to be taken by the Company or Hong Ye and the Company shall, within
ten business days of such forfeiture, pay Convertible Payable in cash.

 

3.
It shall be a condition precedent to the obligations of the Company to complete any registration pursuant Section 3 that Hong Ye
shall furnish to the Company in a timely manner such information regarding Hong Ye, the Conversion Shares and the intended method of disposition
as shall be reasonably required to effect and maintain the effectiveness of the registration of the Conversion Shares and Hong Ye shall
execute such documents in connection with such registration as the Company may reasonably request In furtherance of the foregoing, Hong
Ye shall furnish to the Company a completed and executed questionnaire provided by the Company requesting information customarily sought
of selling security holders.

 

4.
The obligations of Hong Ye pursuant to this Agreement are subject (i) to the Company and SolarMax entering into an amendment to
the Merger Agreement pursuant to which SolarMax and the Company agree to the terms of this Agreement and (ii) the completion of the Merger.
The Company agrees that it will enter into such amendment to the Merger Agreement which includes such a provision and the Company has
been advised by SolarMax that it will agree to such a provision.

 

5. Representations,
Warranties and Covenants of the Parties.

 

(a) Representations,
Warranties and Covenants of the Company. The Company hereby makes the following representations, warranties and covenants to Hong
Ye:

 

(i)
Issuance of Conversion Shares. The Shares to be issued to Hong Ye have been duly authorized
by all necessary corporate action and the Conversion Shares, when issued in accordance with the terms hereof, shall be validly issued
and outstanding, fully paid and non-assessable.

 

(ii) Authorization.
The Company has full power and authority to enter into this Agreement, and this Agreement, when executed and delivered, will
constitute a valid and legally binding and enforceable obligation of the Company, except as enforceability may be limited by
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or other similar laws relating to or affecting the rights
and remedies of creditors or by general equitable principles (whether considered in a proceeding at law or in equity) relating to
enforceability.

 

(b) Representations,
Warranties and Covenants of Hong Ye. The Company is issuing the Conversion Shares to Hong Ye in reliance upon the following representations
made by Underwriter:

 

(i) Hong
Ye has received all the information it considers necessary or appropriate for deciding whether to acquire the Conversion Shares and each
portion thereof. Hong Ye has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions
of the Merger and each portion thereof and the business, properties, prospects and financial condition of the Company and SolarMax and
to obtain additional information necessary to verify the accuracy of any information furnished to Hong Ye or to which Hong Ye had access.

 

    2

     

    

 

(ii)
Hong Ye has full power and authority to enter into this Agreement, and this Agreement, when executed and delivered, will constitute
a valid and legally binding obligation of Hong Ye, except as enforceability may be limited by bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable
principles (whether considered in a proceeding at law or in equity). Hong Ye is the sole lawful record and beneficial of the owner of
the Hong Ye Notes and no person has any right, option or interest in the Hong Ye Notes, and the each of the Hone Ye Notes is not subject
to any option, security interest, pledge, right of first refusal, spousal right or any other right or encumbrance of any kind and description,
and Hong Ye is not a party to any agreement or informal understanding with respect to any of the foregoing.

 

(iii)
Hong Ye agrees that Hong Ye will not engage in any transactions in the stock of the Company (including the successor pursuant to
the Merger Agreement) or aid or assist others in engaging in any such transactions while in possession of material non-public information
concerning the Company or SolarMax.

 

6.
Governing Law. This Agreement shall be governed by the laws of the State of New York applicable to agreement executed and
to be performed wholly within such State without reference to the choice of laws rules of such state. No legal suit, action or proceeding
arising out of or relating to this Agreement, may be commenced, prosecuted or continued in any court other than the courts of the State
of New York located in the City and County of New York or in the United States District Court for the Southern District of New York, which
courts (collectively, the “Specified Courts”). The Parties hereby irrevocably and unconditionally waive any objection to the
laying of venue of in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any Specified
Court that any action or proceeding brought in any Specified Court has been brought in an inconvenient forum.

 

7. This
Agreement shall be binding upon each party hereto and its respective successors and assigns.

 

8. If
any term of provision of this Agreement or any application thereof shall be held invalid or unenforceable, the remainder of this Agreement
and any other application of such term or provision shall not be affected thereby.

 

9.
This Agreement constitutes the entire agreement among the Parties relating to the subject matter hereof, superseding any and all prior
or contemporaneous oral and written agreements, understandings and letters of intent. This Agreement may not be modified or amended nor
may any right be waived except by a writing which expressly refers to this Agreement, states that it is a modification, amendment or waiver
and is signed by both Parties with respect to a modification or amendment or the Party granting the waiver with respect to a waiver. No
course of conduct or dealing and no trade custom or usage shall modify any provisions of this Agreement..

 

10.
All provisions of this Agreement shall be interpreted according to their fair meaning and shall not be strictly construed against either
Party.

 

11.
This Agreement may be executed in one or more counterparts, each of which shall be an original, but all of which, taken together, shall
constitute one agreement. An original signature or copy thereof transmitted by facsimile shall constitute an original signature for purposes
of this Agreement.

 

[Signature Page Follows]

 

    3

    

    

 

IN WITNESS WHEREOF, the
undersigned have executed this Agreement as of the Effective Date.

 

COMPANY

 

	Alberton Acquisition Corporation	 
	 	 
	By:	/s/ Guan Wang	 
	Name:	Guan Wang	 
	Title:	Chief Executive Officer	 

 

HONG YE 

 

	Hong Ye Hong Kong Shareholding Co., Limited	 
	 	 	 
	By:	/s/ Guan Wang	 
	Name:	Guan Wang	 
	Title:	Director	 

 

    4

    

    

 

Schedule A

Working Capital Loans

 

	Date	 	Nature	 	Amount	 
	7/6/2018	 	Promissory Note	 	$	300,000	 
	1/24/2020	 	Promissory Note	 	$	780,000	 
	3/3/2021	 	Promissory Note	 	$	273,640	 

 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]